XML 25 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from (used for) operating activities:    
Net income $ 174 $ 173
Adjustments to reconcile net income to net cash flows from (used for) operating activities:    
Depreciation and amortization 164 146
Deferred tax benefit and tax credits (29) (23)
Other 4 5
Other changes in assets and liabilities:    
Accounts receivable (126) (119)
Regulatory liabilities (60) (38)
Deferred income taxes 58 50
Pension and other benefit obligations (16) (31)
Other (24) (3)
Net cash flows from (used for) operating activities 145 160
Cash flows from (used for) investing activities:    
Utility business construction and acquisition expenditures (214) (278)
Other construction and acquisition expenditures (17) (11)
Cash receipts on sold receivables 209 123
Other (16) (13)
Net cash flows from (used for) investing activities (38) (179)
Cash flows from (used for) financing activities:    
Common stock dividends (102) (93)
Proceeds from issuance of common stock, net 8 228
Proceeds from issuance of long-term debt 0 300
Payments to retire long-term debt 0 (300)
Net change in commercial paper and other short-term borrowings (53) (67)
Other 2 (8)
Net cash flows from (used for) financing activities (145) 60
Net increase (decrease) in cash, cash equivalents and restricted cash (38) 41
Cash, cash equivalents and restricted cash at beginning of period 56 18
Cash, cash equivalents and restricted cash at end of period 18 59
Supplemental cash flows information:    
Interest (59) (65)
Significant non-cash investing and financing activities:    
Accrued capital expenditures 64 156
Beneficial interest obtained in exchange for securitized accounts receivable 107 188
IPL [Member]    
Cash flows from (used for) operating activities:    
Net income 82 86
Adjustments to reconcile net income to net cash flows from (used for) operating activities:    
Depreciation and amortization 94 86
Other (3) (15)
Other changes in assets and liabilities:    
Accounts receivable (133) (126)
Regulatory assets (16) (9)
Regulatory liabilities (19) 1
Deferred income taxes 14 15
Other (64) (13)
Net cash flows from (used for) operating activities (45) 25
Cash flows from (used for) investing activities:    
Utility business construction and acquisition expenditures (106) (165)
Cash receipts on sold receivables 209 123
Other (5) (11)
Net cash flows from (used for) investing activities 98 (53)
Cash flows from (used for) financing activities:    
Common stock dividends (101) (60)
Capital contributions from parent 0 100
Other 9 4
Net cash flows from (used for) financing activities (92) 44
Net increase (decrease) in cash, cash equivalents and restricted cash (39) 16
Cash, cash equivalents and restricted cash at beginning of period 50 9
Cash, cash equivalents and restricted cash at end of period 11 25
Supplemental cash flows information:    
Interest (37) (41)
Income taxes, net 7 0
Significant non-cash investing and financing activities:    
Accrued capital expenditures 31 92
Beneficial interest obtained in exchange for securitized accounts receivable 107 188
WPL [Member]    
Cash flows from (used for) operating activities:    
Net income 84 90
Adjustments to reconcile net income to net cash flows from (used for) operating activities:    
Depreciation and amortization 69 59
Deferred tax benefit and tax credits (28) (11)
Other 4 (5)
Other changes in assets and liabilities:    
Regulatory liabilities (41) (39)
Deferred income taxes 44 32
Other 16 22
Net cash flows from (used for) operating activities 148 148
Cash flows from (used for) investing activities:    
Utility business construction and acquisition expenditures (108) (113)
Other (11) (11)
Net cash flows from (used for) investing activities (119) (124)
Cash flows from (used for) financing activities:    
Common stock dividends (42) (43)
Capital contributions from parent 125 25
Net change in commercial paper and other short-term borrowings (109) 14
Other (4) (1)
Net cash flows from (used for) financing activities (30) (5)
Net increase (decrease) in cash, cash equivalents and restricted cash (1) 19
Cash, cash equivalents and restricted cash at beginning of period 3 4
Cash, cash equivalents and restricted cash at end of period 2 23
Supplemental cash flows information:    
Interest (21) (21)
Significant non-cash investing and financing activities:    
Accrued capital expenditures $ 32 $ 62